Immediate Impact
1 by Nobel laureates 62 standout
Citing Papers
Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics
2023 Standout
Emerging diagnostics and therapeutics for Alzheimer disease
2023 Standout
Works of Debra Lappin being referenced
Assessing what matters most to patients with or at risk for Alzheimer’s and care partners: a qualitative study evaluating symptoms, impacts, and outcomes
2020
RE-ENGINEERING ALZHEIMER CLINICAL TRIALS: GLOBAL ALZHEIMER’S PLATFORM NETWORK
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Debra Lappin | 25 | 17 | 56 | 86 | 73 | 8 | 282 | |
| Spencer Flynn | 9 | 14 | 7 | 55 | 21 | 10 | 279 | |
| Chang-Wan Han | 55 | 20 | 17 | 32 | 77 | 10 | 327 | |
| Rita Girolimetti | 21 | 4 | 12 | 118 | 125 | 7 | 324 | |
| Meredith Lotz | 6 | 2 | 5 | 40 | 65 | 7 | 293 | |
| Susan Oliver | 24 | 29 | 17 | 165 | 15 | 8 | 313 | |
| Jin‐Young Jeong | 11 | 14 | 12 | 76 | 14 | 7 | 204 | |
| P. Smith | 15 | 13 | 17 | 64 | 18 | 9 | 303 | |
| Mark Ratcliffe | 28 | 14 | 101 | 21 | 155 | 8 | 313 | |
| KB Hagen | 34 | 24 | 21 | 99 | 55 | 13 | 303 | |
| Campbell F. MacEachern | 21 | 37 | 17 | 59 | 9 | 11 | 264 |
All Works
Loading papers...